{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:28:11Z","timestamp":1788323291556,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>There is a local renin-angiotensin system (RAS) in the ovary, which is involved in regulating many important physiological processes, but the specific mechanism remains unclear. Polycystic ovarian syndrome (PCOS) is the most frequently reported non-iatrogenic condition with abnormal RAS expression, characterized by overweight or obesity and insulin resistance (IR), both of which are significantly correlated with many long-term complications. These conditions are closely linked to circulatory or local RAS, serving as potential common regulatory nodes. The present study analyzed single-cell RNA sequencing (scRNA-seq) data from mouse ovaries during the reproductive period to obtain the expression levels and location information of RAS components in all cell clusters. It further analyzed the cyclical fluctuations of RAS and the differential gene sets during the estrous cycle. Protein-protein interaction analysis predicted the most closely interacting pathway with RAS, and preliminary evidence of crosstalk between angiotensin II (AngII) and the insulin signaling pathway was identified in the scRNA-seq data. A PCOS mouse model was constructed, replicating clinical reproductive and metabolic complications, and the crosstalk between AngII and IRS1\/PI3K\/AKT was verified. In conclusion, this study revealed the dynamic changes of the ovarian local RAS at the cellular level during the estrous cycle, and described the role of RAS in regulating ovarian function from a single-cell perspective. It also provided evidence that IR, caused by the crosstalk between AngII and IRS1\/PI3K\/AKT pathways, may be a potential underlying mechanism of PCOS.<\/jats:p>","DOI":"10.1038\/s41420-025-02531-8","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:24:20Z","timestamp":1748359460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Single cell RNA sequencing reveals the role of local renin-angiotensin system in regulating ovarian physiological cycle and promoting PCOS"],"prefix":"10.1038","volume":"11","author":[{"given":"Lun","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangtao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruofan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0418-1075","authenticated-orcid":false,"given":"Caiping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"2531_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/med.21996","volume":"44","author":"A Rao","year":"2024","unstructured":"Rao A, Bhat SA, Shibata T, Giani JF, Rader F, Bernstein KE, et al. Diverse biological functions of the renin-angiotensin system. Med Res Rev. 2024;44:587\u2013605.","journal-title":"Med Res Rev"},{"key":"2531_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1210\/er.2009-0012","volume":"30","author":"MA Edson","year":"2009","unstructured":"Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev. 2009;30:624\u2013712.","journal-title":"Endocr Rev"},{"key":"2531_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg L, Hallstr\u00f6m BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteom. 2014;13:397\u2013406.","journal-title":"Mol Cell Proteom"},{"key":"2531_CR4","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.fertnstert.2021.08.009","volume":"116","author":"Y Choi","year":"2021","unstructured":"Choi Y, Jeon H, Br\u00e4nnstr\u00f6m M, Akin JW, Curry TE Jr, Jo M. Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary. Fertil Steril. 2021;116:1631\u201340.","journal-title":"Fertil Steril"},{"key":"2531_CR5","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1093\/humrep\/dex072","volume":"32","author":"IK Cavallo","year":"2017","unstructured":"Cavallo IK, Dela Cruz C, Oliveira ML, Del Puerto HL, Dias JA, Lobach VN, et al. Angiotensin-(1-7) in human follicular fluid correlates with oocyte maturation. Hum Reprod. 2017;32:1318\u201324.","journal-title":"Hum Reprod"},{"key":"2531_CR6","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.fertnstert.2008.04.026","volume":"91","author":"E Acosta","year":"2009","unstructured":"Acosta E, Pe\u00f1a O, Naftolin F, Avila J, Palumbo A. Angiotensin II induces apoptosis in human mural granulosa-lutein cells, but not in cumulus cells. Fertil Steril. 2009;91:1984\u20139.","journal-title":"Fertil Steril"},{"key":"2531_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1080285","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Hao H, Lan T, Jia R, Cao M, Zhou L, et al. Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system. Front Endocrinol. 2022;13:1080285.","journal-title":"Front Endocrinol"},{"key":"2531_CR8","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1177\/1933719116672588","volume":"23","author":"A Palumbo","year":"2016","unstructured":"Palumbo A, \u00c1vila J, Naftolin F. The ovarian renin-angiotensin system (OVRAS): a major factor in ovarian function and disease. Reprod Sci. 2016;23:1644\u201355.","journal-title":"Reprod Sci"},{"key":"2531_CR9","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.3390\/ijms21134572","volume":"21","author":"K Domi\u0144ska","year":"2020","unstructured":"Domi\u0144ska K. Involvement of ACE2\/Ang-(1-7)\/MAS1 axis in the regulation of ovarian function in mammals. Int J Mol Sci. 2020;21:4572.","journal-title":"Int J Mol Sci"},{"key":"2531_CR10","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.fertnstert.2005.05.043","volume":"84","author":"E Zulian","year":"2005","unstructured":"Zulian E, Sartorato P, Schiavi F, Moghetti P, Castello R, Mantero F, et al. The M235T polymorphism of the angiotensinogen gene in women with polycystic ovary syndrome. Fertil Steril. 2005;84:1520\u20131.","journal-title":"Fertil Steril"},{"key":"2531_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00879-w","volume":"14","author":"H Chaudhary","year":"2021","unstructured":"Chaudhary H, Patel J, Jain NK, Joshi R. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis. J Ovarian Res. 2021;14:125.","journal-title":"J Ovarian Res"},{"key":"2531_CR12","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1007\/s43032-021-00786-x","volume":"29","author":"C Chen","year":"2022","unstructured":"Chen C, Wang WF, Yang GL, Guo C. Association between angiotensin-converting enzyme gene I\/D polymorphism and polycystic ovary syndrome susceptibility: a meta-analysis. Reprod Sci. 2022;29:2536\u201345.","journal-title":"Reprod Sci"},{"key":"2531_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/09513590.2019.1695248","volume":"36","author":"K O\u017cegowska","year":"2020","unstructured":"O\u017cegowska K, Bartkowiak-Wieczorek J, Bogacz A, Seremak-Mrozikiewicz A, Duleba AJ, Pawelczyk L. Relationship between adipocytokines and angiotensin converting enzyme gene insertion\/deletion polymorphism in lean women with and without polycystic ovary syndrome. Gynecol Endocrinol. 2020;36:496\u2013500.","journal-title":"Gynecol Endocrinol"},{"key":"2531_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrendo.2016.157","volume":"12","author":"JA Boyle","year":"2016","unstructured":"Boyle JA, Teede HJ. PCOS: Refining diagnostic features in PCOS to optimize health outcomes. Nat Rev Endocrinol. 2016;12:630\u20131.","journal-title":"Nat Rev Endocrinol"},{"key":"2531_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diab Endocrinol. 2022;10:668\u201380.","journal-title":"Lancet Diab Endocrinol"},{"key":"2531_CR16","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations From the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108:2447\u201369.","journal-title":"J Clin Endocrinol Metab"},{"key":"2531_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.4239\/wjd.v12.i5.616","volume":"12","author":"K Unluhizarci","year":"2021","unstructured":"Unluhizarci K, Karaca Z, Kelestimur F. Role of insulin and insulin resistance in androgen excess disorders. World J Diab. 2021;12:616\u201329.","journal-title":"World J Diab"},{"key":"2531_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.","journal-title":"BMC Med"},{"key":"2531_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36:487\u2013525.","journal-title":"Endocr Rev"},{"key":"2531_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nrendo.2014.102","volume":"10","author":"CN Jayasena","year":"2014","unstructured":"Jayasena CN, Franks S. The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol. 2014;10:624\u201336.","journal-title":"Nat Rev Endocrinol"},{"key":"2531_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219\u201331.","journal-title":"Nat Rev Endocrinol"},{"key":"2531_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37:467\u2013520.","journal-title":"Endocr Rev"},{"key":"2531_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Prim. 2016;2:16057.","journal-title":"Nat Rev Dis Prim"},{"key":"2531_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023;120:767\u201393.","journal-title":"Fertil Steril"},{"key":"2531_CR25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","volume":"33","author":"NEH Mimouni","year":"2021","unstructured":"Mimouni NEH, Paiva I, Barbotin AL, Timzoura FE, Plassard D, Le Gras S, et al. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab. 2021;33:513\u2013530.e8.","journal-title":"Cell Metab"},{"key":"2531_CR26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2015.04.005","volume":"58","author":"AA Kolodziejczyk","year":"2015","unstructured":"Kolodziejczyk AA, Kim JK, Svensson V, Marioni JC, Teichmann SA. The technology and biology of single-cell RNA sequencing. Mol Cell. 2015;58:610\u201320.","journal-title":"Mol Cell"},{"key":"2531_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mam.2017.07.003","volume":"59","author":"E Hedlund","year":"2018","unstructured":"Hedlund E, Deng Q. Single-cell RNA sequencing: technical advancements and biological applications. Mol Asp Med. 2018;59:36\u201346.","journal-title":"Mol Asp Med"},{"key":"2531_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.694","volume":"12","author":"D Jovic","year":"2022","unstructured":"Jovic D, Liang X, Zeng H, Lin L, Xu F, Luo Y. Single-cell RNA sequencing technologies and applications: A brief overview. Clin Transl Med. 2022;12:e694.","journal-title":"Clin Transl Med"},{"key":"2531_CR29","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cell.2024.01.021","volume":"187","author":"I Winkler","year":"2024","unstructured":"Winkler I, Tolkachov A, Lammers F, Lacour P, Daugelaite K, Schneider N, et al. The cycling and aging mouse female reproductive tract at single-cell resolution. Cell. 2024;187:981\u201398.e25.","journal-title":"Cell"},{"key":"2531_CR30","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.3390\/ijms23116048","volume":"23","author":"C Gutierrez-Rodelo","year":"2022","unstructured":"Gutierrez-Rodelo C, Arellano-Plancarte A, Hernandez-Aranda J, Landa-Galvan HV, Parra-Mercado GK, Moreno-Licona NJ, et al. Angiotensin II inhibits insulin receptor signaling in adipose cells. Int J Mol Sci. 2022;23:6048.","journal-title":"Int J Mol Sci"},{"key":"2531_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.metabol.2019.03.006","volume":"95","author":"DF Lelis","year":"2019","unstructured":"Lelis DF, Freitas DF, Machado AS, Crespo TS, Santos SHS. Angiotensin-(1-7), adipokines and inflammation. Metabolism. 2019;95:36\u201345.","journal-title":"Metabolism"},{"key":"2531_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.biopha.2018.10.191","volume":"109","author":"F Graus-Nunes","year":"2019","unstructured":"Graus-Nunes F, Souza-Mello V. The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis. Biomed Pharmacother. 2019;109:639\u201345.","journal-title":"Biomed Pharmacother"},{"key":"2531_CR33","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S1357-2725(02)00179-6","volume":"35","author":"PS Leung","year":"2003","unstructured":"Leung PS, Chappell MC. A local pancreatic renin-angiotensin system: endocrine and exocrine roles. Int J Biochem Cell Biol. 2003;35:838\u201346.","journal-title":"Int J Biochem Cell Biol"},{"key":"2531_CR34","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/ijms25021310","volume":"25","author":"E Szczepanska-Sadowska","year":"2024","unstructured":"Szczepanska-Sadowska E. Interplay of angiotensin peptides, vasopressin, and insulin in the heart: experimental and clinical evidence of altered interactions in obesity and diabetes mellitus. Int J Mol Sci. 2024;25:1310.","journal-title":"Int J Mol Sci"},{"key":"2531_CR35","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1172\/JCI119752","volume":"100","author":"F Folli","year":"1997","unstructured":"Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin\/angiotensin II crosstalk. J Clin Invest. 1997;100:2158\u201369.","journal-title":"J Clin Invest"},{"key":"2531_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1095\/biolreprod.111.097808","volume":"86","author":"KA Walters","year":"2012","unstructured":"Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod. 2012;86:149\u201312.","journal-title":"Biol Reprod"},{"key":"2531_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.cmet.2010.06.010","volume":"12","author":"KJ Brothers","year":"2010","unstructured":"Brothers KJ, Wu S, DiVall SA, Messmer MR, Kahn CR, Miller RS, et al. Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor. Cell Metab. 2010;12:295\u2013305.","journal-title":"Cell Metab"},{"key":"2531_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1095\/biolreprod.114.120063","volume":"91","author":"H Lai","year":"2014","unstructured":"Lai H, Jia X, Yu Q, Zhang C, Qiao J, Guan Y, et al. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome. Biol Reprod. 2014;91:127.","journal-title":"Biol Reprod"},{"key":"2531_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01337-5","volume":"17","author":"S Gao","year":"2024","unstructured":"Gao S, Wang J, Wei L, Luo C, Qian F, Bo L, et al. Trehalosemodulates OVRAS to improve oxidative stress and apoptosis in KGN cells and ovaries of PCOS mice. J Ovarian Res. 2024;17:11.","journal-title":"J Ovarian Res"},{"key":"2531_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.rbmo.2021.10.024","volume":"44","author":"A Ullah","year":"2022","unstructured":"Ullah A, Wang MJ, Yang JP, Adu-Gyamfi EA, Czika A, Sah SK, et al. Ovarian inflammatory mRNA profiles of a dehydroepiandrosterone plus high-fat diet-induced polycystic ovary syndrome mouse model. Reprod Biomed Online. 2022;44:791\u2013802.","journal-title":"Reprod Biomed Online"},{"key":"2531_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0015-0282(16)48740-6","volume":"44","author":"LA Fernandez","year":"1985","unstructured":"Fernandez LA, Tarlatzis BC, Rzasa PJ, Caride VJ, Laufer N, Negro-Vilar AF, et al. Renin-like activity in ovarian follicular fluid. Fertil Steril. 1985;44:219\u201323.","journal-title":"Fertil Steril"},{"key":"2531_CR42","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1210\/en.2002-220787","volume":"144","author":"AP Costa","year":"2003","unstructured":"Costa AP, Fagundes-Moura CR, Pereira VM, Silva LF, Vieira MA, Santos RA, et al. Angiotensin-(1-7): a novel peptide in the ovary. Endocrinology. 2003;144:1942\u20138.","journal-title":"Endocrinology"},{"key":"2531_CR43","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1152\/physrev.00036.2005","volume":"86","author":"M Paul","year":"2006","unstructured":"Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86:747\u2013803.","journal-title":"Physiol Rev"},{"key":"2531_CR44","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444\u20138.","journal-title":"Science"},{"key":"2531_CR45","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/CIRCRESAHA.123.321883","volume":"132","author":"MC Chappell","year":"2023","unstructured":"Chappell MC. Renin-angiotensin system and sex differences in COVID-19: a critical assessment. Circ Res. 2023;132:1320\u201337.","journal-title":"Circ Res"},{"key":"2531_CR46","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1016\/j.jacc.2020.04.028","volume":"75","author":"A Brojakowska","year":"2020","unstructured":"Brojakowska A, Narula J, Shimony R, Bander J. Clinical implications of SARS-CoV-2 interaction with renin angiotensin system: JACC review topic of the week. J Am Coll Cardiol. 2020;75:3085\u201395.","journal-title":"J Am Coll Cardiol"},{"key":"2531_CR47","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126:1456\u201374.","journal-title":"Circ Res"},{"key":"2531_CR48","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1126\/science.3529392","volume":"233","author":"N Glorioso","year":"1986","unstructured":"Glorioso N, Atlas SA, Laragh JH, Jewelewicz R, Sealey JE. Prorenin in high concentrations in human ovarian follicular fluid. Science. 1986;233:1422\u20134.","journal-title":"Science"},{"key":"2531_CR49","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1210\/jcem-62-3-613","volume":"62","author":"MD Culler","year":"1986","unstructured":"Culler MD, Tarlatzis BC, Lightman A, Fernandez LA, Decherney AH, Negro-Vilar A, et al. Angiotensin II-like immunoreactivity in human ovarian follicular fluid. J Clin Endocrinol Metab. 1986;62:613\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"2531_CR50","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/0002-9378(87)90336-X","volume":"156","author":"A Lightman","year":"1987","unstructured":"Lightman A, Tarlatzis BC, Rzasa PJ, Culler MD, Caride VJ, Negro-Vilar AF, et al. The ovarian renin-angiotensin system: renin-like activity and angiotensin II\/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluid. Am J Obstet Gynecol. 1987;156:808\u201316.","journal-title":"Am J Obstet Gynecol"},{"key":"2531_CR51","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.fertnstert.2010.06.060","volume":"95","author":"FM Reis","year":"2011","unstructured":"Reis FM, Bouissou DR, Pereira VM, Camargos AF, dos Reis AM, Santos RA. Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary. Fertil Steril. 2011;95:176\u201381.","journal-title":"Fertil Steril"},{"key":"2531_CR52","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/S0015-0282(97)81436-7","volume":"67","author":"A Delbaere","year":"1997","unstructured":"Delbaere A, Bergmann PJ, Gervy-Decoster C, Deschodt-Lanckman M, de Maertelaer V, Staroukine M, et al. Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation. Fertil Steril. 1997;67:1038\u201345.","journal-title":"Fertil Steril"},{"key":"2531_CR53","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/humrep\/12.2.236","volume":"12","author":"A Delbaere","year":"1997","unstructured":"Delbaere A, Bergmann PJ, Gervy-Decoster C, Camus M, de Maertelaer V, Englert Y. Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome. Hum Reprod. 1997;12:236\u201340.","journal-title":"Hum Reprod"},{"key":"2531_CR54","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1126\/science.3381087","volume":"240","author":"A Pellicer","year":"1988","unstructured":"Pellicer A, Palumbo A, DeCherney AH, Naftolin F. Blockage of ovulation by an angiotensin antagonist. Science. 1988;240:1660\u20131.","journal-title":"Science"},{"key":"2531_CR55","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1126\/science.245.4920.871","volume":"245","author":"F Naftolin","year":"1989","unstructured":"Naftolin F, Andrade-Gordon P, Pellicer A, Palumbo A, Apa R, Zreik T, et al. Angiotensin II: does it have a direct obligate role in ovulation?. Science. 1989;245:870\u20131.","journal-title":"Science"},{"key":"2531_CR56","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.fertnstert.2009.03.092","volume":"93","author":"O Pe\u00f1a","year":"2010","unstructured":"Pe\u00f1a O, Palumbo A, Gonz\u00e1lez-Fern\u00e1ndez R, Hern\u00e1ndez J, Naftolin F, Avila J. Expression of angiotensin II type 1 (AT1) and angiotensin II type 2 (AT2) receptors in human granulosa-lutein (GL) cells: correlation with infertility diagnoses. Fertil Steril. 2010;93:1601\u20138.","journal-title":"Fertil Steril"},{"key":"2531_CR57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.theriogenology.2023.04.009","volume":"205","author":"CA Martinez","year":"2023","unstructured":"Martinez CA, Rizos D, Rodriguez-Martinez H, Funahashi H. Oocyte-cumulus cells crosstalk: new comparative insights. Theriogenology. 2023;205:87\u201393.","journal-title":"Theriogenology"},{"key":"2531_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7934","volume":"6","author":"C Liu","year":"2015","unstructured":"Liu C, Peng J, Matzuk MM, Yao HH. Lineage specification of ovarian theca cells requires multicellular interactions via oocyte and granulosa cells. Nat Commun. 2015;6:6934.","journal-title":"Nat Commun"},{"key":"2531_CR59","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1210\/en.2011-1146","volume":"152","author":"R Ferreira","year":"2011","unstructured":"Ferreira R, Gasperin B, Rovani M, Santos J, Barreta M, Bohrer R, et al. Angiotensin II signaling promotes follicle growth and dominance in cattle. Endocrinology. 2011;152:4957\u201365.","journal-title":"Endocrinology"},{"key":"2531_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1530\/rep.0.1250425","volume":"125","author":"K Mitsube","year":"2003","unstructured":"Mitsube K, Mikuni M, Matousek M, Zackrisson U, Br\u00e4nnstr\u00f6m M. Role of the angiotensin II system in regulation of ovulation and blood flow in the rat ovary. Reproduction. 2003;125:425\u201335.","journal-title":"Reproduction"},{"key":"2531_CR61","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1006\/bbrc.1995.1229","volume":"207","author":"M Tanaka","year":"1995","unstructured":"Tanaka M, Ohnishi J, Ozawa Y, Sugimoto M, Usuki S, Naruse M, et al. Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells. Biochem Biophys Res Commun. 1995;207:593\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"2531_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0002-9378(89)90077-X","volume":"160","author":"A Palumbo","year":"1989","unstructured":"Palumbo A, Jones C, Lightman A, Carcangiu ML, DeCherney AH, Naftolin F. Immunohistochemical localization of renin and angiotensin II in human ovaries. Am J Obstet Gynecol. 1989;160:8\u201314.","journal-title":"Am J Obstet Gynecol"},{"key":"2531_CR63","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/0002-9378(85)90464-8","volume":"153","author":"JE Sealey","year":"1985","unstructured":"Sealey JE, McCord D, Taufield PA, Ales KA, Druzin ML, Atlas SA, et al. Plasma prorenin in first-trimester pregnancy: relationship to changes in human chorionic gonadotropin. Am J Obstet Gynecol. 1985;153:514\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"2531_CR64","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1210\/jcem-65-2-349","volume":"65","author":"FH Derkx","year":"1987","unstructured":"Derkx FH, Alberda AT, de Jong FH, Zeilmaker FH, Makovitz JW, Schalekamp MA. Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failure. J Clin Endocrinol Metab. 1987;65:349\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"2531_CR65","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1210\/clinem\/dgaa582","volume":"105","author":"RE Wiegel","year":"2020","unstructured":"Wiegel RE, Jan Danser AH, Steegers-Theunissen RPM, Laven JSE, Willemsen SP, Baker VL, et al. Determinants of maternal renin-angiotensin-aldosterone-system activation in early pregnancy: insights from 2 cohorts. J Clin Endocrinol Metab. 2020;105:3505\u201317.","journal-title":"J Clin Endocrinol Metab"},{"key":"2531_CR66","first-page":"906","volume":"75","author":"J Itskovitz","year":"1992","unstructured":"Itskovitz J, Rubattu S, Levron J, Sealey JE. Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy. J Clin Endocrinol Metab. 1992;75:906\u201310.","journal-title":"J Clin Endocrinol Metab"},{"key":"2531_CR67","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1172\/JCI114121","volume":"83","author":"KJ Shaw","year":"1989","unstructured":"Shaw KJ, Do YS, Kjos S, Anderson PW, Shinagawa T, Dubeau L, et al. Human decidua is a major source of renin. J Clin Investig. 1989;83:2085\u201392.","journal-title":"J Clin Investig"},{"key":"2531_CR68","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/humrep\/dead030","volume":"38","author":"RE Wiegel","year":"2023","unstructured":"Wiegel RE, Danser AHJ, van Duijn L, Willemsen SP, Laven JSE, Steegers EAP, et al. Circulating maternal prorenin and oocyte and preimplantation embryo development: the Rotterdam Periconception Cohort. Hum Reprod. 2023;38:582\u201395.","journal-title":"Hum Reprod"},{"key":"2531_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.111118","volume":"522","author":"RE Wiegel","year":"2021","unstructured":"Wiegel RE, von Versen-H\u00f6ynck F, Steegers-Theunissen RPM, Steegers EAP, Danser AHJ. Prorenin periconceptionally and in pregnancy: does it have a physiological role?. Mol Cell Endocrinol. 2021;522:111118.","journal-title":"Mol Cell Endocrinol"},{"key":"2531_CR70","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/01.CIR.0000054611.89228.92","volume":"107","author":"E Vermes","year":"2003","unstructured":"Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation. 2003;107:1291\u20136.","journal-title":"Circulation"},{"key":"2531_CR71","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/dmrr.489","volume":"20","author":"J Damas","year":"2004","unstructured":"Damas J, Garbacki N, Lef\u00e8bvre PJ. The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity. Diab Metab Res Rev. 2004;20:288\u201397.","journal-title":"Diab Metab Res Rev"},{"key":"2531_CR72","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11906-012-0323-2","volume":"15","author":"PC Underwood","year":"2013","unstructured":"Underwood PC, Adler GK. The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep. 2013;15:59\u201370.","journal-title":"Curr Hypertens Rep"},{"key":"2531_CR73","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18:618\u201337.","journal-title":"Hum Reprod Update"},{"key":"2531_CR74","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1159\/000351572","volume":"22","author":"Z Alphan","year":"2013","unstructured":"Alphan Z, Berberoglu Z, Gorar S, Candan Z, Aktas A, Aral Y, et al. Increased total renin levels but not angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome. Med Princ Pract. 2013;22:475\u20139.","journal-title":"Med Princ Pract"},{"key":"2531_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105965","volume":"214","author":"AE Butler","year":"2021","unstructured":"Butler AE, Moin ASM, Sathyapalan T, Atkin SL. Vitamin D association with the renin angiotensin system in polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2021;214:105965.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2531_CR76","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3109\/09513590.2013.769513","volume":"29","author":"S Arefi","year":"2013","unstructured":"Arefi S, Mottaghi S, Sharifi AM. Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs). Gynecol Endocrinol. 2013;29:470\u20133.","journal-title":"Gynecol Endocrinol"},{"key":"2531_CR77","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/dmrr.611","volume":"22","author":"LA Velloso","year":"2006","unstructured":"Velloso LA, Folli F, Perego L, Saad MJ. The multi-faceted cross-talk between the insulin and angiotensin II signaling systems. Diab Metab Res Rev. 2006;22:98\u2013107.","journal-title":"Diab Metab Res Rev"},{"key":"2531_CR78","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11892-007-0007-5","volume":"7","author":"Z Liu","year":"2007","unstructured":"Liu Z. The renin-angiotensin system and insulin resistance. Curr Diab Rep. 2007;7:34\u201342.","journal-title":"Curr Diab Rep"},{"key":"2531_CR79","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1161\/01.ATV.0000140059.04717.f3","volume":"24","author":"MB Marrero","year":"2004","unstructured":"Marrero MB, Fulton D, Stepp D, Stern DM. Angiotensin II-induced insulin resistance and protein tyrosine phosphatases. Arterioscler Thromb Vasc Biol. 2004;24:2009\u201313.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2531_CR80","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1042\/CS20130333","volume":"126","author":"FP Dominici","year":"2014","unstructured":"Dominici FP, Burghi V, Mu\u00f1oz MC, Giani JF. Modulation of the action of insulin by angiotensin-(1-7). Clin Sci. 2014;126:613\u201330.","journal-title":"Clin Sci"},{"key":"2531_CR81","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s12276-023-00982-6","volume":"55","author":"JW Lee","year":"2023","unstructured":"Lee JW, Gu HO, Jung Y, Jung Y, Seo SY, Hong JH, et al. Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation. Exp Mol Med. 2023;55:910\u201325.","journal-title":"Exp Mol Med"},{"key":"2531_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120269","volume":"291","author":"B Alexandre-Santos","year":"2022","unstructured":"Alexandre-Santos B, Magliano DC, Giori IG, Medeiros GRO, Vieira CP, Conte-Junior CA, et al. Renin-angiotensin system modulation through enalapril and\/or exercise training improves visceral adiposity in obese mice. Life Sci. 2022;291:120269.","journal-title":"Life Sci"},{"key":"2531_CR83","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","volume":"13","author":"NS Kalupahana","year":"2012","unstructured":"Kalupahana NS, Moustaid-Moussa N. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev. 2012;13:136\u201349.","journal-title":"Obes Rev"},{"key":"2531_CR84","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.3390\/ijms24043814","volume":"24","author":"NTH Nguyen","year":"2023","unstructured":"Nguyen NTH, Nguyen PA, Huang CW, Wang CH, Lin MC, Hsu MH, et al. Renin-angiotensin-aldosterone system inhibitors and development of gynecologic cancers: a 23 million individual population-based study. Int J Mol Sci. 2023;24:3814.","journal-title":"Int J Mol Sci"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02531-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02531-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02531-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:03:22Z","timestamp":1748361802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02531-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2531"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02531-8","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The work has been reported in line with the ARRIVE guidelines 2.0. The study design and protocol were approved and adopted by the Ethics Committee of the First Affiliated Hospital of Soochow University on September 13, 2022 with approval number of 2022(359). This experiment does not involve human participants (including the use of tissue samples) and any clinical trials.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"255"}}